"Attention of the Holders of Securities in Physical Mode is invited to Circular No. SEBI/HO/MIRSD/PoD-1/P/CIR/2023/181 dated November 17, 2023 issued by SEBI."
Home
About Us
Company Profile
Corporate ETHOS
Mission
Vision
Board of Directors and KMPs
Board Committees
Products
Speciality Chemicals
Skin Care Products
Hospital Care Products
Generics
Investors
Financial Information
Investor Information
Annual Reports
Shareholding Pattern
Corporate Governance
Policies
Other Data
Newsapaper Publication
Shareholders Meetings/Other Disclosures
Disclosure under Reg 46 of SEBI (LODR) Regulations 2015.
Media
News & Press Release
Contact Us
Q2
Closure of Trading Window
Compliances-Reg. 39 (3) - Details of Loss of Certificate - Duplicate Certificate
Announcement under Regulation 30 (LODR)-Acquisition
Shareholder Meeting - Postal Ballot-Scrutinizer''s Report
Shareholder Meeting - Postal Ballot-Outcome of AGM
Compliances-Reg. 39 (3) - Details of Loss of Certificate - Duplicate Certificate
Compliances-Reg. 39 (3) - Details of Loss of Certificate - Duplicate Certificate
Compliances-Reg. 39 (3) - Details of Loss of Certificate-Duplicate Certificate
Intimation Of Submission Of Application To BSE Limited For Reclassification Of Promoters Of Pharmaids Pharmaceuticals Limited (''''Company'''')
Announcement under Regulation 30 (LODR)-Newspaper Publication
Notice Of Convening The 34Th Annual General Meeting (AGM)
Announcement under Regulation 30 (LODR)-Resignation of Director
Announcement under Regulation 30 (LODR)-Change in Management
Board Meeting Outcome for For Approval Of Annual Financial Statements For The Financial Year 2022-23 And AGM Related Matters
Compliances-Reg. 39 (3) - Details of Loss of Certificate -Duplicate Certificate
Announcement under Regulation 30 (LODR)-Updates on Acquisition
Announcement under Regulation 30 (LODR)-Updates on Acquisition
Newspaper advertisement - Financial Results of Quarter and Three Months ended
Intimation under Regulation 30- Reappointment of Secretarial Auditor of the Company
Submission of Unaudited Standalone and Consolidated Financial Results along with
Outcome of the Board Meeting and Disclosure under Regulation 30
Intimation of the Board Meeting
Announcement Under Regulation 31A(8)(A) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015
Announcement Under Regulation 31A(8)(A) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015
Announcement Under Regulation 31A(8)(A) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015
Announcement Under Regulation 31A(8)(A) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliances-Reg. 39 (3) - Details of Loss of Certificate -Duplicate Certificate
Home
About Us
Company Profile
Corporate ETHOS
Mission
Vision
Products
Personal Care Ingredients
Generics Ingredients
Hospital Care Products
Sking Care Products
Investors
Financial Information
Board of Directors
Annual Reports
Listing Updates
Shareholding Pattern
Corporate Governance
Half Yearly Compliances
Media
News & Press Release
Corporate Announcement
Gallery
Contact Us
